Skip to main content
. 2018 Feb 7;275(4):967–972. doi: 10.1007/s00405-018-4891-x

Table 1.

Diagnoses

Salivary gland neoplasms 49.5%
 Benign salivary gland neoplasms 36.4%
  Pleomorphic adenoma 31 (31.3%)
  Monomorphic 4 (4.0%)
  Warthin 1 (1.0%)
 Malignant salivary gland neoplasms 13.1%
  Adenoid cystic carcinoma 4 (4.0%)
  Carcinoma ex pleomorphic adenoma 3 (3.0%)
  Adenocarcinoma NOS 3 (3.0%)
  Acinic cell carcinoma 2 (2.0%)
  Myoepithilial carcinoma 1 (1.0%)
Neurogenic neoplasms 41.4%
 Paraganglioma 30 (30.3%)
  Carotid body paraganglioma 20
  Vagal paraganglioma 17
  Jugular paraganglioma 1
 Schwannoma 9 (9.1%)
 Neurofibroma 2 (2.0%)
Miscellaneous lesions 9.1%
 (Lympho)vascular malformation 2 (2.0%)
 Lymphoma non-Hodgkin 1 (1.0%)
 Rhabdomyoma 1 (1.0%)
 Rhabdomyosarcoma 1 (1.0%)
 Branchial cyst 1 (1.0%)
 Metastasis 3 (3.0%)